Interestingly, NOTCH1 mutations in CLL are correlated with low BAX/BCL-2 ratios [76] and a recent study suggested that NOTCH1 activation provides growth advantage to CLL cells to potentially escape venetoclax induced apoptosis [77]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.